The clinical information you need, at your fingertips.

The first-in-class therapy helped some patients maintain viral control after treatment ended, potentially reducing reliance on lifelong antiviral therapy. . .

In a small, uncontrolled study, breast cancer survivors with persistent brain fog moved from impaired to normal-range cognitive scores after 8 weeks of treatment. . .

Intensive exposure-based therapy produced greater symptom improvement, remission, and treatment satisfaction than internet-based CBT in adults with obsessive-compulsive disorder. . .

In a large real-world cohort of midlife women, hormone therapy was linked to greater and more sustained weight loss with semaglutide. . .